Top Page
Nanollose Ltd.
(Sydney:NC6)
Nanollose Ltd. (NC6) vs. S&P 500 (SPY)
Nanollose Ltd. Business Overview & Revenue Model
Nanollose Ltd. Financial Statement Overview
| Breakdown | ||||
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 12.50K | 412.16K | 224.61K | 322.86K | 461.85K | Gross Profit |
| -348.95K | 58.29K | -223.55K | -70.57K | -12.71K | EBIT |
| -1.25M | -1.27M | -1.71M | -1.08M | -1.60M | EBITDA |
| -1.10M | -1.16M | -1.51M | -873.73K | -1.31M | Net Income Common Stockholders |
| -1.16M | -1.35M | -1.57M | -931.04K | -1.24M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 138.75K | 548.25K | 1.59M | 3.01M | 839.16K | Total Assets |
| 241.95K | 633.24K | 1.91M | 3.38M | 1.02M | Total Debt |
| 42.53K | 11.52K | 38.09K | 37.88K | 58.12K | Net Debt |
| -96.22K | -536.73K | -1.55M | -2.97M | -781.04K | Total Liabilities |
| 465.64K | 181.61K | 181.51K | 507.83K | 236.75K | Stockholders Equity |
| -223.69K | 451.63K | 1.73M | 2.87M | 785.22K |
| Cash Flow | Free Cash Flow | |||
| -900.95K | -1.01M | -1.39M | -1.01M | -946.68K | Operating Cash Flow |
| -900.95K | -1.01M | -1.38M | -935.19K | -945.59K | Investing Cash Flow |
| 15.97K | 0.00 | -5.35K | -272.15K | -1.09K | Financing Cash Flow |
| 475.49K | -26.57K | -32.69K | 3.37M | 663.14K |
Nanollose Ltd. Technical Analysis
Nanollose Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $6.54B | 17.17 | 6.85% | 4.63% | -5.64% | ― | |
52 Neutral | $5.35B | 3.96 | -42.60% | 2.86% | 17.58% | 1.27% | |
43 Neutral | AU$30.70M | ― | -96.97% | ― | -64.97% | 9.89% | |
40 Underperform | AU$10.75M | ― | -1014.79% | ― | -70.17% | -41.07% | |
33 Underperform | €120.34M | ― | -8.78% | ― | ― | 17.83% | |
21 Underperform | AU$6.71M | ― | -1051.45% | ― | 205.01% | -28.57% |
Nanollose Ltd. Corporate Events
Nanollose Limited has made significant strides in product development and commercialization, particularly with its Nullarbor sustainable fiber and Biollose soilless horticulture divisions. A key milestone was the successful pilot production of wool blankets incorporating Nullarbor-20 fiber with Waverley Mills, marking the first time this fiber has been blended with wool. This development highlights the versatility of Nullarbor fibers and opens up access to high-value markets. Additionally, Nanollose received a $272,000 payment as part of a strategic capital raise, providing financial flexibility to advance its R&D and commercialization objectives.
Nanollose Ltd. announced the issuance of 3,400,000 unquoted equity securities, specifically options expiring on April 30, 2028. This move is part of the company’s strategic financial operations, potentially impacting its capital structure and providing opportunities for future growth and investment within the sustainable textile industry.
Nanollose Limited has successfully completed a pilot production of approximately 70 small blankets in collaboration with Waverley Mills, Australia’s premier woollen mill. This marks the first time Nullarbor-20 fiber has been blended with wool, demonstrating its versatility and potential for high-value applications in the textile industry. The project highlights the seamless integration of Nullarbor-20 into existing manufacturing facilities, supporting sustainable fabric solutions and expanding commercial opportunities for Nanollose.
Nanollose Ltd. has announced the issuance of 179,978 fully paid ordinary securities, which will be quoted on the Australian Securities Exchange (ASX) under the code NC6. This move could enhance the company’s financial flexibility and strengthen its market position by potentially attracting more investors interested in sustainable materials.
Nanollose Limited has announced the appointment of Mr. Winton Willesee and Mr. Timothy Barker as Joint Company Secretaries, following the retirement of Mrs. Erlyn Dawson. This change in governance is part of the company’s ongoing efforts to strengthen its operational framework. The announcement underscores Nanollose’s commitment to maintaining robust communication channels with the ASX, reflecting its strategic focus on sustainable innovation in the biomaterials industry.
Nanollose Ltd. announced a change in the director’s interest, with Mr. Winton Willesee acquiring additional shares and options through a rights issue and as compensation for director fees. This change reflects the company’s strategic financial adjustments and may impact its governance and financial structure, potentially influencing stakeholder confidence and market perception.
Nanollose Ltd. announced a change in the director’s interest, where Dr. Wayne Best acquired 12,500,000 fully paid ordinary shares and 2,500,000 unlisted options as compensation for director fees owed. This move, approved by shareholders, reflects the company’s strategy to manage its financial obligations while aligning the interests of its leadership with its operational goals.
Nanollose Ltd. has announced that ConBrio Beteiligungen AG, along with several associated entities and individuals, has become a substantial holder in the company, acquiring a 5.46% voting power through the purchase of 12,705,657 fully paid ordinary shares. This acquisition signifies a significant investment in Nanollose, potentially impacting its market positioning and stakeholder interests, as ConBrio and its associates have acquired these shares through various transactions over recent months.
Nanollose Limited has announced that ConBrio Beteiligungen AG, along with several associated entities, has become a substantial holder in the company, acquiring a 5.48% voting power through the purchase of 10,788,117 fully paid ordinary shares. This development indicates a significant investment interest from ConBrio Beteiligungen AG and its associates, potentially impacting Nanollose’s market positioning and stakeholder dynamics by aligning with influential investors from Germany and Australia.
Nanollose Ltd. has issued a notification regarding the issuance, conversion, or payment of unquoted equity securities, correcting a previous announcement due to a technical error. The update clarifies that a total of 12,159,219 options are to be issued, addressing a duplication error in the previous communication.
Nanollose Ltd. announced the issuance of unquoted equity securities, specifically options expiring on April 30, 2028. This move is part of previously announced transactions and reflects the company’s strategic efforts to strengthen its financial position and support its growth initiatives in the sustainable materials market.
Nanollose Ltd. has announced the quotation of 35,759,950 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of February 27, 2025. This move is part of previously announced transactions and is expected to enhance the company’s financial positioning, potentially impacting its market presence and offering new opportunities for stakeholders.
Nanollose Limited has completed its non-renounceable rights issue offer, initially announced in January 2025, which allowed eligible shareholders to subscribe for additional shares. The offer aimed to raise approximately $1,050,701, but resulted in a significant shortfall of 54,873,275 shares, which will be open for placement by strategic investor Dutch Ink (2010) Pty Ltd for up to three months. This development reflects the company’s ongoing efforts to secure funding for its innovative biomaterials projects and could impact its financial strategy and stakeholder relations.
Nanollose Limited reported a significant increase in its financial loss for the half-year ending December 31, 2024, with losses up by 40% to $725,681 compared to the previous year. The company’s net tangible assets have decreased significantly, indicating potential financial challenges and raising concerns about its market positioning and future sustainability.
Nanollose Limited held a General Meeting where all resolutions were decided by a poll. The company continues to develop its Tree-Free cellulose technology, with successful pilot production runs in collaboration with Birla Cellulose, producing over a tonne of fibres. These fibres are being tested and evaluated by collaborators, indicating potential future adoption by partners.